8.1 C
New York
Saturday, February 21, 2026

Merck pays Moderna $250m for personalized cancer vaccine

Pharma giant Merck has paid Moderna $250 million to co-develop and commercialize its promising mRNA-based personalized cancer vaccine.

This post was originally published on this site

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments

Stay Connected

149,500FansLike
396,312FollowersFollow
2,650SubscribersSubscribe

Latest Articles

0
Would love your thoughts, please comment.x
()
x